Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies
This activity is supported by an unrestricted educational grant from Allergan.
Business Matters: Avoiding Burnout
Editorially independent content supported with advertising by Bausch + Lomb and Regeneron
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored By Allergan
The AMD Treatment Burden: Current Status and Promising Solutions
This activity is supported by a grant from Genentech, a member of the Roche Group.